Devicor® Medical Products, Inc. Completes Acquisition of Neoprobe’s Gamma Detection Devices

August 17, 2011

Cincinnati, OH Deal adds key building block to Devicor’s growth strategy. Devicor® Medical Products, Inc. (“Devicor”), a portfolio company of GTCR, a leading private equity firm, announced today the completion of its previously announced agreement to acquire the neoprobe® gamma detection system …

GTCR Announces Acquisition of BankServ

August 16, 2011

Chicago, IL Investment to help accelerate growth of leading financial technology franchise. GTCR, a leading private equity firm, today announced it has agreed to acquire a majority stake in BankServ, Inc. (“BankServ”), a leading SaaS (software-as-a-service) provider offering financial services and banking …

GTCR Announces Agreement to Partner with Emmis Communications to Acquire Merlin Media LLC

June 21, 2011

Chicago, IL GTCR, a leading private equity firm, today announced it has signed a definitive agreement to partner with Emmis Communications Corporation (Nasdaq: EMMS) and Randy Michaels to acquire Merlin Media LLC (“Merlin Media”), a company which owns and operates media …

Devicor™ Medical Products, Inc. Agrees to Acquire Neoprobe’s Gamma Detection Devices

May 25, 2011

Cincinnati, OH Deal adds key building block to Devicor’s growth strategy. Devicor™ Medical Products, Inc. (“Devicor”), a portfolio company of leading private equity firm GTCR, announced today it has signed an asset purchase agreement with Neoprobe Corporation to acquire the neoprobe® GDS …

GTCR Wins Private Equity Firm of the Year Award

May 19, 2011

Chicago, IL The M&A Advisor recognizes GTCR with top award. GTCR, a leading private equity firm, announced that it won the Private Equity Firm of the Year Award during The M&A Advisor’s 6th Annual M&A Financing Awards Gala at the Drake Hotel …

Actient Pharmaceuticals LLC Announces Acquisition of Striant® (Testosterone Buccal System) from Columbia Laboratories, Inc.

April 20, 2011

Lake Forest, IL Actient Pharmaceuticals LLC (“Actient”) announced today that it has acquired the U.S. rights to Striant® (testosterone buccal system) from Columbia Laboratories, Inc. Striant utilizes a novel mucoadhesive technology that allows for oral administration of testosterone using buccal absorption. …

GTCR Closes the Acquisition of Sterigenics International, Inc.

March 28, 2011

Chicago, IL GTCR, a leading private equity firm, today announced it has successfully completed the acquisition of Sterigenics International, Inc. (“Sterigenics”), the leading global provider of contract sterilization and ionization services for medical devices, food products and advanced applications, from Silverfleet …

GTCR Announces Partnership with Jim Henderson and Tom Riley to Form Assured Agencies

March 1, 2011

Chicago, IL GTCR, a leading private equity firm, today announced it has entered into a partnership with Jim Henderson and Tom Riley to form Assured Agencies (“Assured”). The new company, headquartered in Lake Mary, Florida, will focus on building a leading …

GTCR Announces Agreement to Acquire Sterigenics International, Inc.

February 23, 2011

Chicago, IL GTCR, a leading private equity firm, today announced it has signed a definitive agreement with Silverfleet Capital and PPM America Capital Partners to acquire Sterigenics International, Inc. (“Sterigenics”), the leading global provider of contract sterilization and ionization services for …

GTCR Closes $3.25 Billion Buyout Fund

February 22, 2011

Chicago, IL Leading private equity firm exceeds target in just seven months. GTCR, one of the nation’s leading private equity firms today announced the final closing of its 10th buyout fund, with more than $3.25 billion of equity capital commitments. The fund, which …
Close
Close
Close
Close
Close